Basaglar Insulin Glargine 100 Units / mL Solution for Injection in Pre-filled Pen

? Drug Name:

Basaglar Insulin Glargine 100 Units / mL Solution for Injection in Pre-filled Pen

? Strength:

100 Units / mL

? Dosage Form:

Pre-filled Pen for Injection

? Description

Basaglar contains insulin glargine, a long-acting insulin that is very similar to human insulin.
It is used to treat diabetes in adults, adolescents, and children aged 2 years and above.
Diabetes is a condition where the body does not produce enough insulin to control blood sugar levels. Insulin glargine helps reduce blood sugar levels in a consistent and long-lasting manner.

? How to Use

• Attach a new needle before every use.
• Use only compatible needles.
• Inspect the cartridge before using the pen. Do not use Basaglar KwikPen if you notice particles. Only use it if the solution is clear, colorless, and water-like.
• Do not shake or mix the solution before use.
• To avoid potential contamination, do not share the pen with others.
• Inject under the skin only (subcutaneously). Do not inject intravenously as it may alter the effect and cause hypoglycemia (low blood sugar).
• The injection site should be rotated within the designated skin area.
• The best injection sites are the abdomen, thigh, upper arm, or buttocks.
• Always use a new pen if you notice that blood sugar control is worsening unexpectedly.
• Do not refill the pens. Dispose of used pens properly.

⚠ Warnings and Precautions

Consult your doctor or pharmacist before using Basaglar if you have:

• Skin changes at the injection site, such as lumps under the skin (ensure proper injection technique to avoid such changes).
• Sick or injured conditions, as they may affect your blood sugar control.
• Travel plans, as you need to discuss the availability of insulin and storage conditions in the destination country.
• Changes in diet or physical activity that may affect your insulin needs.
• Heart failure, particularly if you are taking insulin along with pioglitazone for Type 2 diabetes, as it may increase the risk of heart failure.

? Side Effects

Basaglar may cause side effects, although not everyone experiences them. Potential side effects include:

• Hypoglycemia (low blood sugar)
• Skin changes at the injection site (e.g., lumps or bumps)
• Allergic reactions
• Vision problems
• Joint swelling
• Heart failure symptoms such as rapid weight gain, shortness of breath, or swelling.

? Drug Interactions

Tell your doctor if you are taking any other medications, especially:

• Medications for birth control, pain, hormonal therapy, diabetes, high blood pressure, asthma, or depression.
• Any over-the-counter drugs.

? Storage

• Before opening: Store in the refrigerator (2°C to 8°C), away from the cooling element. Do not freeze.
• During use or when traveling: Store at temperatures below 30°C or refrigerate (2°C to 8°C) for up to 4 weeks.
• Do not freeze the pen.
• Keep the pen cap on to protect it from light.

? Ingredients

The active ingredient is insulin glargine.
Each mL of solution contains 100 Units of insulin glargine (equivalent to 3.64 mg).
Other ingredients include: zinc oxide, meta-cresol, glycerin, and sodium hydroxide.

ℹ Important Notes

• Regular blood sugar monitoring is necessary.
• Always follow your doctor's instructions for insulin dosage and blood tests.
• Do not stop using this medication without consulting your doctor.